| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |